Sobre el grupo
Investigador Principal
Luis Palomera Bernal
Equipo
Alberto Argón Arcarazo, Beatriz Martínez Lázaro, Clara Garcia Castell, Ericka Inés Castro Trujillo, Esther Franco García, Fernando Joaquin Sevil Puras, Gemma Azaceta Reinares, Guillermo Haces Tirado, José Antonio Moreno Chulilla, Luis Antonio Mayor Pérez, Luis Ignacio Sancho Val, Mª del Mar Moles Guerrero, Mª Elena Bonafonte Arruga, Mª Isabel Miravete Duque, Mª Teresa Olave Rubio, Mª Victoria Dourdil Sahún, Manuela Dobon Rebollo, Miguel Paricio Moreno, Nahum García Lorente, Natalia María Gemperle Ortiz, Olga Gavín Sebastián, Pedro José Paul Viladlle, Rosana Díez Angulo, Sonia Angós Vázquez, Victoria Minerva Murillo Cortés
Hospital Clínico Universitario Lozano Blesa
Líneas de Investigación
Estudios translaccionales de inmunoterapia aplicada a patología linfoide
Investigación en enfermedades oncohematológicas
Investigación en patología trombótica
Investigación en patología hematológica no oncológica
Publicaciones más relevantes
Hernandez-Boluda J, Pereira A, Pastor-Galan I, Alvarez-Larran A, Savchuk A, Puerta J, Sanchez-Pina J, Collado R, Diaz-Gonzalez A, Angona A, Sagues M, Garcia-Gutierrez V, Boque C, Osorio S, Vallansot R, Palomera L, Mendizabal A, Casado L, Perez-Encinas M, Perez-Lopez R, Ferrer-Marin F, Sanchez-Guijo F, Garcia C, de las Heras N, Lopez-Lorenzo J, Cervantes F, Steegmann J, GELMC. Feasibility of treatment discontinuation in chronic myeloid leukemia in clinical practice: results from a nationwide series of 236 patients. Blood Cancer J. 2018. 8: 91. 10.1038/s41408-018-0125-0.
Jimenez-Ubieto A, Grande C, Caballero D, Yanez L, Novelli S, Hernandez-Garcia M, Manzanares M, Arranz R, Ferreiro J, Bobillo S, Mercadal S, Galeo A, Jimenez J, Moraleda J, Vallejo C, Albo C, Perez E, Marrero C, Magnano L, Palomera L, Jarque I, Martinez-Sanchez P, Martin A, Coria E, Lopez-Guillermo A, Salar A, Lahuerta J, GELTAMO Grp Espanol Linfomas Tr. Autologous stem cell transplantation may be curative for patients with follicular lymphoma with early therapy failure who reach complete response after rescue treatment. Hematol Oncol. 2018. 36(5): 765 - 772. 10.1002/hon.2553.
Sanoja-Flores L, Flores-Montero J, Garces J, Paiva B, Puig N, Garcia-Mateo A, Garcia-Sanchez O, Corral-Mateos A, Burgos L, Blanco E, Hernandez-Martin J, Pontes R, Diez-Campelo M, Millacoy P, Rodriguez-Otero P, Prosper F, Merino J, Vidriales M, Garcia-Sanz R, Romero A, Palomera L, Rios-Tamayo R, Perez-Andres M, Blanco J, Gonzalez M, van Dongen J, Durie B, Mateos M, San-Miguel J, Orfao A, EuroFlow Consortium. Next generation flow for minimally-invasive blood characterization of MGUS and multiple myeloma at diagnosis based on circulating tumor plasma cells (CTPC). Blood Cancer J. 2018. 8: 117. 10.1038/s41408-018-0153-9.
Rodriguez-Otero P, Mateos M, Martinez-Lopez J, Martin-Calvo N, Hernandez M, Ocio E, Rosinol L, Martinez R, Teruel A, Gutierrez N, Bargay J, Bengoechea E, Gonzalez Y, de Oteyza J, Gironella M, Encinas C, Martin J, Cabrera C, Palomera L, de Arriba F, Cedena M, Paiva B, Puig N, Oriol A, Blade J, Lahuerta J, San Miguel J. Early myeloma-related death in elderly patients: development of a clinical prognostic score and evaluation of response sustainability role. Leukemia. 2018. 32(11): 2427 - 2434. 10.1038/s41375-018-0072-6.
Casado L, Garcia-Ormena N, Mba C, Garcia-Gutierrez J, Giraldo P, Perez-Encinas M, De Paz R, Ayala R, Bautista G, Osorio S, Requena M, Palomera L, Penarrubia M, Calle C, Hernandez-Rivas J, Steegmann J. ANALYSIS OF DEEP MOLECULAR RESPONSES ACHIEVED BY THE MULTIPLE SEQUENCES OF TREATMENTS WITH ITKS IN LMC. LONG FOLLOW-UP STUDY OF THE LMC SPANISH REGISTRY. Haematologica. 2018. 103: 231 - 231. .
Lopez-Anglada L, Cueto-Felgueroso C, Rosinol L, Oriol A, Teruel A, de la Guia A, Bengoechea E, Palomera L, de Arriba F, Hernandez J, Granell M, Penalver F, Garcia-Sanz R, Besalduch J, Gonzalez Y, Martinez R, Hernandez M, Gutierrez N, Puerta P, Valeri A, Paiva B, Blade J, Mateos M, San Miguel J, Lahuerta J, Martinez-Lopez J, GEM Grp Espanol MM, PETHEMA Programa El Estudio. Prognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA/GEM phase III clinical trials. PLoS One. 2018. 13(9): e0203392. 10.1371/journal.pone.0203392.
Jimenez-Ubieto A, Grande C, Caballero D, Yanez L, Hernandez-Garcia M, Novelli S, Arranz R, Ferreiro J, Bobillo S, Mercadal S, Galeo A, Jimenez J, Moraleda J, Vallejo C, Albo C, Perez E, Marrero C, Magnano L, Palomera L, Jarque I, Martinez-Sanchez P, Martin A, Coria E, Lopez-Guillermo A, Salar A, Lahuerta J, Cooperative Study Grp. Secondary malignancies and survival outcomes after autologous stem cell transplantation for follicular lymphoma in the pre-rituximab and rituximab eras: a long-term follow-up analysis from the Spanish GELTAMO registry. Bone Marrow Transplant.. 2018. 53(6): 780 - 783. 10.1038/s41409-018-0096-6.
Sebastian O, Fernandez M, Fernandez R, Bernal L. Anticoagulation with rivaroxaban in a hematology unit: clinical profile, events and discontinuation rates in real-life patients with nonvalvular atrial fibrillation. Futur. Cardiol.. 2018. 14(3): 25 - 30. 10.2217/fca-2018-0023.